FindMyKOL
Clinical trialNCT02058004CompletedInterventional

Does Cricoid Pressure Reduce the Risk of Aspiration?

NCT02058004 is an interventional trial sponsored by Mayo Clinic. As of 18 Nov 2026, it is completed. It studies Acute Respiratory Distress Syndrome (ARDS), Hospital Acquired Pneumonia and 1 more condition. The registry lists an enrollment of 95 participants at 2 sites in 1 country. The registry lists a start date of 31 Aug 2014 and a primary completion date of 31 Oct 2014.

SponsorMayo Clinic →Enrollment95Acute Respiratory Distress Syndrome (ARDS)Hospital Acquired PneumoniaMicroaspiration
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT02058004
FieldValue
Registry IDNCT02058004
StatusCompleted
Study typeInterventional trial
Lead sponsorMayo Clinic
Enrollment95
Registered sites2
Countries1
ConditionsAcute Respiratory Distress Syndrome (ARDS), Hospital Acquired Pneumonia and Microaspiration
Start31 Aug 2014
Primary completion31 Oct 2014
Study completion31 Oct 2014
Last update posted1 Jan 2016

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

In modern anesthesia practice, the application of cricoid pressure during intubation is not infrequently used with the goal of preventing gastric-to-pulmonary aspiration. The evidence to support this practice is very scarce, and there have recently been many reports in the literature questioning the safety of cricoid pressure during intubation. Therefore, the goal of this study will be to randomize those at risk for microaspiration to receive cricoid pressure versus no cricoid pressure during intubation. We will specifically exclude those patients thought to be at the highest risk of aspiration (it is considered standard of care to perform cricoid pressure during intubation of this population). We will include those patients with some risk factors for aspiration (it is not considered standard of care to apply cricoid pressure during intubation of this population).

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Minnesota, United States2 sites
  • Mayo Clinic - Saint Mary's Campus

    Rochester

  • Mayo Clinic in Rochester

    Rochester

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesota: 2 sitesMN2WisconsinWIMichiganMINew YorkNYMassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT02058004

Each answer restates registry values shown on this page.

What is NCT02058004?

NCT02058004 is an interventional trial sponsored by Mayo Clinic. It studies Acute Respiratory Distress Syndrome (ARDS), Hospital Acquired Pneumonia and 1 more condition.

Who leads NCT02058004?

The registry names John Bohman, MD (principal investigator, Mayo Clinic) as the overall official.

Where does NCT02058004 run?

The registry lists 2 sites in 1 country. Every site with a stated country is in one country: United States.

When did NCT02058004 end?

The registry lists a primary completion date of 31 Oct 2014 and a study completion date of 31 Oct 2014. The sponsor last updated the record on 1 Jan 2016.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.